CÚRAM and Factor Bioscience join forces to develop new cell therapy for COVID-19 patients

International research partnership hopes to bring new cell therapy to clinical trial for severe cases of COVID-19 and other ARDS patients within the next year

CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, has announced a new research partnership with US-based biotechnology company, Factor Bioscience Inc., to develop and test a new cell therapy for people with severe COVID infections and other serious respiratory illness.